CoChat

Combinational Proanthocyanidins and Resveratrol Synergistically Inhibit Human Breast Cancer Cells and Impact Epigenetic–Mediating Machinery

Open access
Gao, Yifeng, Tollefsbol, Trygve O. · 2018 · International Journal of Molecular Sciences

The DOI matches its Crossref record; 45 of the 47 references it cites were found in a registry or an index.

Abstract

Breast cancer is the second most common cancer and the second leading cause of death from cancer among women in the United States (US). Cancer prevention and therapy through the use of phytochemicals that have epigenetic properties has gained considerable interest during the past few decades. Such dietary components include, but are not limited to, grape seed proanthocyanidins (GSPs) and resveratrol (Res), both of which are present in red wine. In this study, we report for the first time the synergistic effects of GSPs and Res on inhibiting MDA-MB-231 and MCF-7 human breast cancer cells. Our results of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays and clonogenic assays indicate that treatments with the combinations of GSPs and Res synergistically decreased cell viability and posttreatment cell proliferation in both cell lines. Additional analyses show that treatments with GSPs and Res in combination synergistically induced apoptosis in MDA-MB-231 cells by upregulating Bax expression and down-regulating Bcl-2 expression. DNA methyltransferase (DNMT) activity and histone deacetylase (HDAC) activity were greatly reduced in MDA-MB-231 and MCF-7 cells after treatments with GSPs and Res in combination. Collectively, our findings suggest that GSPs and Res synergistically inhibit human breast cancer cells through inducing apoptosis, as well as modulating DNA methylation and histone modifications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms19082204

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 MTT Assay. Inhibition of cell viability in MDA-MB-231 (A) and MCF-7 (B) human breast cancer cells after treatment with grape seed proanthocyanidins (GSPs) (20, 40 μg/ML), Res (10, 20 μM), and their combinations (20 μg/ML GSPs with 10 μM Res, 40 μg/ML GSPs with 20 μM Res) as compared with the dimethyl sulfoxide (DMSO)-treated control cells for 48 h and 72 h. MCF10A human mammary epithelial cells (C) were used as the control cells to determine the toxicity of these phytochemicals of varying concentrations. Results were generalized from three independent experiments with very similar observations. The cell viability of each treatment group is represented in percentage compared with the control group as the mean ± SD. Mean values without any same superscript letter (lowercase letters for 48 h in MDA-MB-231 and MCF-7 cells and 72 h in MCF10A cells; uppercase letters for 72 h in MDA-MB-231 and MCF-7 cells) were considered to be significantly different (p < 0.05).
Figure 1 MTT Assay. Inhibition of cell viability in MDA-MB-231 (A) and MCF-7 (B) human breast cancer cells after treatment with grape seed proanthocyanidins (GSPs) (20, 40 μg/ML), Res (10, 20 μM), and their combinations (20 μg/ML GSPs with 10 μM Res, 40 μg/ML GSPs with 20 μM Res) as compared with the dimethyl sulfoxide (DMSO)-treated control cells for 48 h and 72 h. MCF10A human mammary epithelial cells (C) were used as the control cells to determine the toxicity of these phytochemicals of varying concentrations. Results were generalized from three independent experiments with very similar observations. The cell viability of each treatment group is represented in percentage compared with the control group as the mean ± SD. Mean values without any same superscript letter (lowercase letters for 48 h in MDA-MB-231 and MCF-7 cells and 72 h in MCF10A cells; uppercase letters for 72 h in MDA-MB-231 and MCF-7 cells) were considered to be significantly different (p < 0.05).CC BY · PubMed Central
Figure 2 Clonogenic Assay. Inhibition of colony forming ability in MDA-MB-231 (A) and MCF-7 (B) human breast cancer cells as well as MCF10A (C) human mammary epithelial cells in seven days after treatment with GSPs (20, 40 μg/ML), Res (10, 20 μM), and their combinations (20 μg/ML GSPs with 10 μM Res, 40 μg/ML GSPs with 20 μM Res) as compared with the DMSO-treated control groups for 48 h. Results were generalized and representative images were selected from three independent experiments with very similar observations. The colony forming ability of each treatment group is represented in percentage compared with the control group as the mean ± SD. Mean values without any same superscript letter were considered significantly different (p < 0.05).
Figure 2 Clonogenic Assay. Inhibition of colony forming ability in MDA-MB-231 (A) and MCF-7 (B) human breast cancer cells as well as MCF10A (C) human mammary epithelial cells in seven days after treatment with GSPs (20, 40 μg/ML), Res (10, 20 μM), and their combinations (20 μg/ML GSPs with 10 μM Res, 40 μg/ML GSPs with 20 μM Res) as compared with the DMSO-treated control groups for 48 h. Results were generalized and representative images were selected from three independent experiments with very similar observations. The colony forming ability of each treatment group is represented in percentage compared with the control group as the mean ± SD. Mean values without any same superscript letter were considered significantly different (p < 0.05).CC BY · PubMed Central
Figure 3 Apoptosis Assay. Morphological and apoptotic changes of MDA-MB-231 (A,C) and MCF-7 (B,D) human breast cancer cells induced by GSPs (20 μg/ML), Res (10 μM), and their combination when compared with the DMSO-treated control groups after treatment for 48 h. The images were taken at 40× magnification under a microscope after the cells were treated for 48 h. Apoptosis analysis was performed by the Annexin V-conjugated Alexafluor 488 (Alexa488) Apoptosis Vybrant Assay Kit and analyzed by FACS. Q1 (the upper left quadrant) of the FACS histogram represents dead cells (stained by propidium iodide) that are not associated with apoptosis. Q2 (the upper right quadrant) represents late apoptotic cells (stained by Alexa488 and propidium iodide). Q3 (the lower left quadrant) represents live cells. Q4 (the lower right quadrant) represents early apoptotic cells (stained by Alexa488). The percentage of all four quadrants of cells from each treatment was indicated in C and D. Results were generalized and representative images were selected from three independent experiments with very similar observations.
Figure 3 Apoptosis Assay. Morphological and apoptotic changes of MDA-MB-231 (A,C) and MCF-7 (B,D) human breast cancer cells induced by GSPs (20 μg/ML), Res (10 μM), and their combination when compared with the DMSO-treated control groups after treatment for 48 h. The images were taken at 40× magnification under a microscope after the cells were treated for 48 h. Apoptosis analysis was performed by the Annexin V-conjugated Alexafluor 488 (Alexa488) Apoptosis Vybrant Assay Kit and analyzed by FACS. Q1 (the upper left quadrant) of the FACS histogram represents dead cells (stained by propidium iodide) that are not associated with apoptosis. Q2 (the upper right quadrant) represents late apoptotic cells (stained by Alexa488 and propidium iodide). Q3 (the lower left quadrant) represents live cells. Q4 (the lower right quadrant) represents early apoptotic cells (stained by Alexa488). The percentage of all four quadrants of cells from each treatment was indicated in C and D. Results were generalized and representative images were selected from three independent experiments with very similar observations.CC BY · PubMed Central
Figure 4 Western Blot Analysis. Change of expression of Bax and Bcl-2 in MDA-MB-231 and MCF-7 human breast cancer cells induced by GSPs (20 μg/ML), Res (10 μM), and their combination when compared with the DMSO-treated control groups after treatment for 48 h (A). β-actin was used to confirm equivalent loading of the protein samples. The relative density of each band was measured by ImageJ and was shown under each blot of Bax and Bcl-2 after normalization to the control. A representative image was selected from three independent experiments with very similar results. The Bax:Bcl-2 protein ratio is represented as the mean ± SD (B). Mean values without any same superscript letter were considered significantly different (p < 0.05).
Figure 4 Western Blot Analysis. Change of expression of Bax and Bcl-2 in MDA-MB-231 and MCF-7 human breast cancer cells induced by GSPs (20 μg/ML), Res (10 μM), and their combination when compared with the DMSO-treated control groups after treatment for 48 h (A). β-actin was used to confirm equivalent loading of the protein samples. The relative density of each band was measured by ImageJ and was shown under each blot of Bax and Bcl-2 after normalization to the control. A representative image was selected from three independent experiments with very similar results. The Bax:Bcl-2 protein ratio is represented as the mean ± SD (B). Mean values without any same superscript letter were considered significantly different (p < 0.05).CC BY · PubMed Central
Figure 5 DNA methyltransferases (DNMT) Activity. Inhibition of DNMT activity in MDA-MB-231 (A) and MCF-7 (B) human breast cancer cells after treatment with GSPs (20 μg/ML), Res (10 μM), and their combination compared with the DMSO-treated control groups for 48 h. Results were generalized from three independent experiments with very similar observations. The DNMT activity of each treatment group is represented in percentage when compared with the control group as the mean ± SD. Mean values without any same superscript letter were considered significantly different (p < 0.05).
Figure 5 DNA methyltransferases (DNMT) Activity. Inhibition of DNMT activity in MDA-MB-231 (A) and MCF-7 (B) human breast cancer cells after treatment with GSPs (20 μg/ML), Res (10 μM), and their combination compared with the DMSO-treated control groups for 48 h. Results were generalized from three independent experiments with very similar observations. The DNMT activity of each treatment group is represented in percentage when compared with the control group as the mean ± SD. Mean values without any same superscript letter were considered significantly different (p < 0.05).CC BY · PubMed Central
Figure 6 HDAC Activity. Inhibition of HDAC activity in MDA-MB-231 (A) and MCF-7 (B) human breast cancer cells after treatment with GSPs (20 μg/ML), Res (10 μM), and their combination compared with the DMSO-treated control groups for 48 h. Results were generalized from three independent experiments with very similar observations. The HDAC activity of each treatment group is represented in percentage as compared with the control group as the mean ± SD. Mean values without any same superscript letter were considered significantly different (p < 0.05).
Figure 6 HDAC Activity. Inhibition of HDAC activity in MDA-MB-231 (A) and MCF-7 (B) human breast cancer cells after treatment with GSPs (20 μg/ML), Res (10 μM), and their combination compared with the DMSO-treated control groups for 48 h. Results were generalized from three independent experiments with very similar observations. The HDAC activity of each treatment group is represented in percentage as compared with the control group as the mean ± SD. Mean values without any same superscript letter were considered significantly different (p < 0.05).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 45 references

Cited by

Metadata

Authors
Gao, Y., & Tollefsbol, T. O.
Affiliations
University of Alabama at Birmingham (US)
Corresponding author
Tollefsbol, Trygve O.
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2018-07-27
Volume
19
Issue
8
Pages
2204
ISSN
1422-0067 (ISSN-L)
OpenAlex
W2883755219
Cited by
90
References
47
Citations by year
2026: 3 · 2025: 11 · 2024: 13 · 2023: 10 · 2022: 17 · 2021: 8 · 2020: 14 · 2019: 12 · 2018: 1
FWCI
5.99
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Institutes of Health (R01 CA178441; R01 CA204346)
Topics
  • Health Sciences › Medicine › Biochemistry (medical) › Phytochemicals and Antioxidant Activities
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
Keywords
grape seed proanthocyanidins, resveratrol, breast cancer, synergistic antitumor effect, apoptosis, Bax, Bcl-2, DNA methylation, histone deacetylase, epigenetic regulation, MDA-MB-231 cells, MCF-7 cells, red wine polyphenols, cell proliferation inhibition
MeSH terms
Resveratrol, Antineoplastic Agents, Phytogenic, Breast Neoplasms, Cell Survival, Drug Synergism, Drug Therapy, Combination, Female, Histone Deacetylases, Humans, Stilbenes, Apoptosis, Epigenesis, Genetic, Proanthocyanidins, Cell Line, Tumor, Cell Proliferation, bcl-2-Associated X Protein, Grape Seed Extract, MCF-7 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.